Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.
about
Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatmentAntiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatmentNew developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseEndovascular interventions in iliac and infrainguinal occlusive artery disease.Minimally invasive revascularization strategies for chronic lower limb ischemia.Current state of endovascular treatment of femoro-popliteal artery disease.Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentMid-Term Outcomes of Stent Overlap in Long Total Occluded Lesions of Superficial Femoral Artery.Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.Treating femoropopliteal disease: established and emerging technologiesEndovascular treatment of femoral-popliteal diseaseThe primary patency and fracture rates of self-expandable nitinol stents placed in the popliteal arteries, especially in the P2 and P3 segments, in Korean patientsGene therapy for cardiovascular angiogenesis.Endovascular intervention for peripheral artery disease.Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery diseaseEndovascular Gene Delivery from a Stent Platform: Gene- Eluting Stents.Endovascular therapies for vascular disease.Endovascular therapies for noncoronary atherosclerosis in the elderly: aortoiliac and femorotibial lesions.Comparison of diamond-like carbon-coated nitinol stents with or without polyethylene glycol grafting and uncoated nitinol stents in a canine iliac artery model.Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease.Carotid artery dynamics after carotid angioplasty and stenting.Comparison of in vitro human endothelial cell response to self-expanding stent deployment in a straight and curved peripheral artery simulator.Drug-eluting stents in the management of peripheral arterial diseaseCurrent endovascular therapy for lower extremity peripheral arterial disease: indications, outcomes and modalities.Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database.Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model.Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.Local drug delivery for treatment of coronary and peripheral artery disease.Drug-eluting stents and balloons in peripheral arterial disease: evidence so far.Drug-coated balloons for coronary and peripheral interventional procedures.Drug-coated balloons and their place in treating peripheral arterial disease.Endovascular stents: a review of their use in peripheral arterial disease.Systematic review and meta-analysis of additional technologies to enhance angioplasty for infrainguinal peripheral arterial occlusive disease.Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.Patterns of disease distribution of lower extremity peripheral arterial disease.Standards of practice for superficial femoral and popliteal artery angioplasty and stenting.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.
P2860
Q24201432-FF40FB66-09CE-4999-B922-6818B0B725E4Q24244985-C74074FE-D380-47A4-8E06-3ABB55835928Q26740218-25125E48-7D41-4DF9-BB12-4A3BB40DCA13Q31128347-E999BF4A-A1A4-43E9-99F5-D7D73C5C9942Q33236821-82C87C6C-A177-47C5-84B3-D6EC6E22D5D1Q33298566-DBAA76E9-88BD-489B-8408-23EF7BD5F74AQ33710114-5CF26684-573A-4681-97AD-97C83B06F69CQ33874462-5E3190F5-D724-4ED5-9DB8-52B1B26615AAQ34227383-CC901BBF-0B38-4B3A-A186-71230B5246BFQ34449178-5EF1F8D2-D413-4D98-81BA-688E8192774CQ34513862-53FA3E52-0FD5-48FB-BD19-72A634DCB8BAQ34563744-BCCD41D8-2D3A-4652-AD1F-D13BF87C264AQ34642030-81C6F8CE-2131-4F65-B207-DC154F3ECF53Q35164797-90AD2EC9-4D39-4E60-A763-7E8A1A59FE42Q35857220-1E64AA8C-BABD-46AC-B484-9E96D4FF46CFQ35866198-A06AE80E-0680-4385-B062-875DA025FA4CQ35893044-C9118A66-745D-41B9-BFE2-544F9CB7516AQ36077843-3C6DB173-5A28-4136-95EB-BACD163152C6Q36193245-8F1AE381-899F-4529-AB78-70644ACC7765Q36325343-22895AA2-085D-4E5B-B601-6F977B649B80Q36587019-82D71160-643D-4222-A3B7-22EE0EFF6294Q36752071-4DA4F74F-2C3E-4001-AA38-AD540766C5C0Q36767954-FD861ECB-2B97-4ADB-AD9F-2A05C66C7057Q36835836-5CBA5CC2-004B-42F5-BEDD-E54704DE3473Q36982443-831A097B-CB25-49D7-9AAC-3229D4AB3C12Q37119681-F5607918-4581-461B-A76A-F59F41FD2060Q37321632-472AE178-105A-4615-AF63-B6116FA2028FQ37371945-3BB77BA1-9F35-4B5B-94F3-0A302D6DE94FQ37456910-73C2D794-E378-451E-B45F-93E4ED6860A8Q37463102-3230CBEB-7A3E-4C13-BC75-960D0455503DQ37765610-690BF98A-0CE4-4ED6-8B92-8C3C4FB45434Q37874693-ACC61A38-AA81-4FC0-B158-E83B2E2A5794Q38028877-710358AA-3491-4D21-B020-455303061691Q38070705-21021A2D-CA4F-43FD-A4B3-31CF43597922Q38098451-88A7843C-5480-4F0B-B95B-545FBAB0AC0FQ38120675-C49703F5-EFE7-4A18-A585-BCE8DB871246Q38133465-59FA5E89-08B8-4D9E-A243-18D66DF03827Q38197822-CEB33396-9061-4613-9C34-A6E6A7256222Q38203809-A7A5B2BB-E92E-4435-A2D2-2534454CF85AQ38211926-E1B6A0C9-0B7D-40DC-93C6-331C4763E889
P2860
Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Sirolimus-eluting stents for t ...... ry disease: six-month results.
@en
type
label
Sirolimus-eluting stents for t ...... ry disease: six-month results.
@en
prefLabel
Sirolimus-eluting stents for t ...... ry disease: six-month results.
@en
P2093
P1433
P1476
Sirolimus-eluting stents for t ...... ry disease: six-month results.
@en
P2093
Alexander Tielbeek
Alexandra Lansky
Benjamin Pusich
Benjamin Wiesinger
Ecatarina Cristea
Gerhard Ziemer
Goetz Richter
Hans Tielemans
Jan Bart Hak
Jean P Bérégi
P304
P356
10.1161/01.CIR.0000029746.10018.36
P407
P577
2002-09-01T00:00:00Z